ID   SNU-80
AC   CVCL_5097
SY   SNU80
DR   cancercelllines; CVCL_5097
DR   Cosmic; 1024884
DR   Cosmic; 1065283
DR   IARC_TP53; 24493
DR   KCLB; 00080
DR   Wikidata; Q54955272
RX   PubMed=17134824;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 37 hours (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>C); ClinVar=VCV000013970; Zygosity=Unspecified (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (PubMed=17134824).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): KCLB=00080
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 12,13
ST   FGA: 20,23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
RX   PubMed=17134824; DOI=10.1016/j.mce.2006.10.017;
RA   Koh C.-S., Ku J.-L., Park S.-Y., Kim K.-H., Choi J.-S., Kim I.-J.,
RA   Park J.-H., Oh S.K., Chung J.-K., Lee J.-H., Kim W.-H., Kim C.W.,
RA   Cho B.Y., Park J.-G.;
RT   "Establishment and characterization of cell lines from three human
RT   thyroid carcinomas: responses to all-trans-retinoic acid and mutations
RT   in the BRAF gene.";
RL   Mol. Cell. Endocrinol. 264:118-127(2007).
//